tykhr
sign in
free sign up
Neuphoria Therapeutics Inc
Biotechnology
Healthcare
NEUP
234 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.94
52 week high
15.10
high
12.04
52 week low
0.00
low
9.88
growth
48.39 %
previous Close
9.86
P/E ratio
2
market cap
96.47 M
div yield
0
usd
Mar 2025
qoq
revenue
15.00 M
2.00 %
net incoming
11.26 M
679.52 %
eps
6.55 %
630.92 %
eps surprise
1.71 %
net profit margin
75.08 %
368.00 %
operating incoming
11.98 M
423.40 %
net change in cash
12.70 M
439.05 %
cash on hand
17.05 M
292.29 %
cost of revenue
165 K
0.00 %
top